Custom MHC Class II HLA-DP Xynapse and Dextramer R
Closed Solicitation Posted
- Solicitation number
- 75N98026Q00782
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 813920 Professional Organizations
- PSC
- R499 Support- Professional: Other
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Office of Logistics and Acquisition Operations seeks custom MHC Class II HLA-DP Xynapse and Dextramer reagents for liver cancer neoantigen validation, with capability statements due July 22, 2026. This is a sole source procurement under FAR 6.302-1, with Immudex USA, LLC/Immudex ApS identified as the only responsible source.
Immudex exclusively owns the proprietary Dextramer technology and manufacturing capability as the original developer and holds the associated intellectual property rights. The contractor has demonstrated consistent prior performance with high-quality products, efficient production, and reliable delivery timelines. Capability statements from any responsible source, including small businesses and women-owned small businesses, are invited to demonstrate ability to meet the requirements and must be submitted to haunp@mail.nih.gov by 9:00 a.m. EDT on July 22. Award is anticipated approximately five days after the closing date unless the Government receives and evaluates responses demonstrating an alternative source's capability. The procurement is not competitive unless credible alternative capability is demonstrated. The NAICS code is 813920, Professional Organizations; the PSC code is R499, Support–Professional: Other.
Notice text
Custom MHC Class II HLA-DP Xynapse and Dextramer Reagents for Liver Cancer Neoantigen Validation
Files
| File | Type | Posted |
|---|---|---|
| 75N98026Q00782_-_Pre-Solicitation_-_Immudex.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity